Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

By  

EPILEPSIA, Vol. 59, Iss. 2, 2018-02 ,pp. : 479-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04)

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 606-616

John Wiley & Sons Inc

Access to resources Recommend Favorite

Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double‐blind, and placebo‐controlled study

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 394-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antihypertensive Treatment in Postmenopausal Women: Results from a Prospective, Randomized, Double-Blind, Controlled Study Comparing an ACE Inhibitor (Moexipril) with a Diuretic (Hydrochlorothiazide)

By  

Cardiology, Vol. 89, Iss. 4, 2008-10 ,pp. : 271-276

Karger

Access to resources Recommend Favorite